This webinar was tailored for melanoma nurses aiming to deepen their understanding of the endocrine complications associated with immunotherapy for people with melanoma. It gave an overview of immunotherapy-related endocrine adverse events, focusing in detail on the effects on the thyroid and pituitary gland, including their recognition, management and long-term implications for patient care. Nurses will gain insight into effective approaches to identifying and managing these complications, equipping them with the knowledge to offer comprehensive care and patient education.
Watch on demand
Event recording
Recording guide
Explore the topics
Open the guide below to see the six topics covered, then select any topic to open the recording at that point on YouTube in a new tab.
Show the 6 topicsHide the topics
Learning outcomes
What you will learn
After this session, nurses will be able to:
01
Identify common endocrine toxicities
Identify common endocrinological toxicities following immunotherapy.
02
Assess thyroid and pituitary toxicities
Demonstrate an understanding of how to assess patients for signs and symptoms of endocrinological toxicities related to the thyroid and pituitary gland.
03
Deliver patient-centred education and support
Demonstrate an understanding of the nurse's role in delivering patient-centred education and support related to the potential endocrinological side effects of immunotherapy.
At a glance
The event in brief
Originally held
Thursday 19 March 2026
Online webinar, part of the National Melanoma Nursing Program.
Who this is for
Nurses
Nurses aiming to deepen their understanding of endocrine complications associated with immunotherapy.
Contributors
Speaker
Speaker
Dr Anna Galligan
General Physician and Endocrinologist, St Vincent's Hospital Melbourne
Dr Anna Galligan is an Endocrinologist and General Physician. She studied medicine at Monash University and underwent dual specialist training through St Vincent's Hospital, the Royal Hobart Hospital and the Royal Melbourne Hospital. Anna consults in all areas of endocrinology. Her interests include diabetes, diabetes technology, women's health, antenatal endocrinology and weight management. Anna holds public appointments in Endocrinology at St Vincent's Hospital Melbourne and the Royal Women's Hospital Melbourne, and is the lead endocrinologist for the St Vincent's Hospital High Risk Foot Service. Anna's research thesis, completed at the University of Melbourne (2021) in conjunction with St Vincent's Institute and Peter MacCallum Cancer Centre, focused on the effects of cancer immunotherapy on the endocrine system.
This webinar was brought to you by
Resource details
